tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market
Advertisement

Lineage Therap (LCTX) Financial Statements

Compare
2,027 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently $369.94M. The company's EPS TTM is $-0.13; its P/E ratio is ―; Lineage Therap is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis